Arkolith/Insider Trading/ONCT/Form 4

Breitmeyer James B

Chief Executive Officer, DirectorOncternal Therapeutics, Inc. (ONCT) · full profile →Form 4 · filed Jan 5, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2024Tax withholding(F)4K$0.50$2K15K
Jan 3, 2024Tax withholding(F)51K$0.50$25K443K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-24-000970) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML